CliniSys Hires Mark Spencer as Senior Vice President of Global Strategy

CliniSys GroupCliniSys announced that Mark Spencer has joined the company as Senior Vice President of Global Strategy. A 25-year veteran in the life sciences and healthcare IT industry, Mark will be charged with driving growth globally.

As the world looks to improve public health now and after the pandemic, Mark will work closely with the senior leadership team to realise CliniSys' vision to support its customers both inside and beyond the walls of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing.

The appointment follows CliniSys' recent acquisition of HORIZON Lab Systems and merger with Sunquest Information Systems. Mark will play a critical role in integrating these business lines and product offerings to help organisations and governments globally better fight disease.

"CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking," said Mark Spencer. "That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally."

A former manager at Sunquest, Mark rejoins from Abbott Informatics, where he led the successful growth of its former laboratory information management system (STARLIMS). Mark began his career in the military, serving six years as a management engineer in the United States Air Force.

"Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector," said CliniSys CEO Michael Simpson. "We are delighted to have him on board for this next stage in our growth."

About CliniSys

CliniSys, headquartered in Chertsey, England and Tucson, Arizona, is one of the largest provider of laboratory information systems, order entry and result consultation, and public health solutions in disease surveillance and outbreak management across the United Kingdom, Europe, and the United States. For 40 years, successfully specialising in complex and the wide scale delivery of comprehensive laboratory and public health solutions in over 3,000 laboratories across 34 countries using CliniSys solutions.

Our combined cross-discipline expertise provides customers with solutions to support laboratory workflow across clinical, histology, molecular, genetics, including order management, reporting and results delivery. Additionally, we serve laboratories in environmental testing, water quality, agriculture, and toxicology.

Most Popular Now

AI Predictions for Colorectal Cancer: On…

Colorectal cancer (CRC) ranks second in leading causes of cancer-related deaths globally, according to the WHO. For the first time, researchers from Helmholtz Munich and the University of Technology Dresden...

Combining AI Models Improves Breast Canc…

Combining artificial intelligence (AI) systems for short- and long-term breast cancer risk results in an improved cancer risk assessment, according to a study published in Radiology, a journal of the...

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

Healthcare Chatbot: Expand Support with …

The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...